FGFR2 and breast carcinoma: Hinting at the possibility that the FGFR2 rs2981578 polymorphism may heighten FGFR2’s transcriptional activity or expression as breast cancer advances, underscoring the potential prognostic value of this genetic variation in breast cancer prognosis [28,39].